TY - JOUR
T1 - Clinical profile of patients with myasthenia gravis followed at the University Hospital, Federal University of Minas Gerais
AU - Mourão, Aline Mansueto
AU - Barbosa, Luiz Sérgio Mageste
AU - Comini-Frota, Elizabeth Regina
AU - Da Silva Freitas, Denise
AU - Gomez, Rodrigo Santiago
AU - Burns, Ted M.
AU - Lemos, Stela Maris Aguiar
AU - Teixeira, Antonio Lúcio
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Objective: to determine the clinical profile of patients with myasthenia gravis (MG); followed at the Neuromuscular Diseases Clinic of the University Hospital, Federal University of Minas Gerais, Brazil, and to compare it with other Brazilian case series. Methods: sociodemographic and clinical data were collected from patients, and a systematic literature review performed, focusing on national studies on the clinical profile of MG patients. Results: sixty nine patients were enrolled in the study. Fifty five (91%) subjects were female and the mean age (SD) was 37.6 (±11.4) years. The mean disease duration was 14.1 years. Regarding treatment, prednisone was the most used strategy (64%), followed by the use of azathioprine (43%). There was no difference between thymectomized (42) and non-thymectomized (27) patients regarding disease severity and medication use. Conclusion: clinical and socio-demographic features of this MG sample from a University-based clinic resemble those reported in other Brazilian series and in the international literature.
AB - Objective: to determine the clinical profile of patients with myasthenia gravis (MG); followed at the Neuromuscular Diseases Clinic of the University Hospital, Federal University of Minas Gerais, Brazil, and to compare it with other Brazilian case series. Methods: sociodemographic and clinical data were collected from patients, and a systematic literature review performed, focusing on national studies on the clinical profile of MG patients. Results: sixty nine patients were enrolled in the study. Fifty five (91%) subjects were female and the mean age (SD) was 37.6 (±11.4) years. The mean disease duration was 14.1 years. Regarding treatment, prednisone was the most used strategy (64%), followed by the use of azathioprine (43%). There was no difference between thymectomized (42) and non-thymectomized (27) patients regarding disease severity and medication use. Conclusion: clinical and socio-demographic features of this MG sample from a University-based clinic resemble those reported in other Brazilian series and in the international literature.
KW - Epidemiology
KW - Myasthenia gravis
KW - Neurology
KW - Therapeutics
KW - Thymectomy
UR - http://www.scopus.com/inward/record.url?scp=84946129564&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946129564&partnerID=8YFLogxK
U2 - 10.1590/1806-9282.61.02.156
DO - 10.1590/1806-9282.61.02.156
M3 - Article
C2 - 26107366
AN - SCOPUS:84946129564
SN - 0104-4230
VL - 61
SP - 156
EP - 160
JO - Revista da Associacao Medica Brasileira
JF - Revista da Associacao Medica Brasileira
IS - 2
ER -